InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Gil Eladio. Director active across 1 company, notably Cano Health, Inc.. Cumulatively, 2 disclosures have been published. History available since 10 November 2023. The latest transaction was filed on 10 November 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations